Access - Pricing - HEOR Courses
Boost your expertise in market access and the key disciplines that drive patient access and product value.
The CELforPharma training programmes below fast-track your development with practical tools and strategic frameworks taught by industry thought leaders. Our small class sizes and interactive formats ensure hands-on learning and valuable peer-to-peer exchange with international colleagues.
Scroll through our course offerings or jump straight to the one that interests you:
COMMERCIAL MARKET ACCESS:
The Pharma Commercial Market Access Course
With Manoj Sood
🎓 What you will learn:
- The role of market access as a commercial growth driver in today's pharmaceutical landscape.
- How to assess health systems and map the decision-makers, barriers, and enablers that determine patient access.
- How to segment and prioritise stakeholders based on investment and influence rather than job title.
- Key frameworks for quantifying the value of your access work in a way that resonates with senior leadership.
- How to lead cross-functional alignment and communicate access strategy upwards with clarity and impact.
PAYER NEGOTIATION:
The Healthcare Payer Negotiations Course
With Dr Stefan Walzer
🎓 What you will learn:
- Understand core negotiation principles and styles: Gain foundational knowledge of what negotiation entails and how to navigate different negotiation styles.
- Develop and apply a structured negotiation strategy: Learn to define clear goals, build strong BATNAs/ZOPAs, and use tactical tools to manage objections and maintain dialogue.
- Tailor negotiation approaches to healthcare payer contexts: Explore the specific dynamics of healthcare negotiations.
- Challenge common payer negotiation myths and biases: Identify and dismantle misconceptions about payer negotiations while learning to foster empathy and understanding.
- Practise and refine negotiation skills through real-world exercises: Collaborate on case-based simulations involving pharma products to create and execute negotiation strategies.
2-day face-to-face course in Brussels:
The AI for Pharma Market Access Course
With Dr Stefan Walzer
1-day live online course:
Introduction to AI in Market Access
With Dr Stefan Walzer
🎓 What you will learn:
- Master the essentials of AI in pharma market access: Understand key terminology, explore the transformative impact of AI, and tackle industry-specific challenges.
- Integrate AI-driven tools with confidence: Learn how to seamlessly incorporate AI into market access processes to boost efficiency and achieve superior outcomes.
- Discover the best AI systems for your needs: Get an overview of available AI technologies, along with their pros and cons, tailored to pharma market access applications.
- Gain hands-on experience with AI in action: Participate in practical exercises using AI-driven tools for market access planning, systematic literature reviews, dossier writing, and payer negotiations.
(Features a real-life prostate cancer case study to simulate and solve real-world challenges across the market access lifecycle.) - Learn from your peers in pharma market access: Benefit from peer insights as they will share their challenges, experiences, and innovative solutions.
MARKET ACCESS IN EUROPE:
Understanding Pharma Market Access & Payers in Europe
With Dr Nick Proctor & Megan O'Brien
🎓 What you will learn:
- The patterns in pricing & reimbursement systems and processes in France, Germany, Italy, Spain and the UK.
- Market access challenges and opportunities in these countries.
- How to differentiate between different categories of payers.
- Payer archetypes and the drivers of their decision-making processes.
- The market access plan and process, and the contributions of internal stakeholders across functions.
- The types of Managed Entry Agreements used by payers and pharma to mitigate risk.
MARKET ACCESS IN THE US:
Understanding Pharma Market Access in the US
With Dr Nick Proctor & Louisa Oliver Byrne
🎓 What you will learn:
- The structure and key players of US Managed Care systems, and how they compare with other global systems.
- The scope of medical benefit and how to navigate the pricing and access control mechanisms in this system.
- The role and significance of Pharmacy Benefit Managers (PBMs) and how to navigate the pricing and access control mechanisms in the pharmacy benefit system.
- The tools and context needed to understand and discuss the potential future impact of the Inflation Reduction Act, increased PBM transparency, and other recent policy decisions.
- Strategies for navigating towards successful market access and how to deal with the most common challenges along the way.
VALUE PRICING:
The Pharma Pricing Course
With Gary Johnson & Sam Johnson
🎓 What you will learn:
- An overview of payer types and of national pricing & market access systems around the world.
- The concepts and language of pharma pricing and market access that confuse many executives.
- The difference between setting prices and defending prices with health economics.
- Talking to payers using surveys, interviews, and AI to get the most accurate assessment of the achievable price.
- Using AI and econometrics to analyse payer behaviour and predict future pricing behaviour.
- How to anticipate the impact of the international pricing system on your prices around the globe.
REAL-WORLD EVIDENCE:
Generating RWE for Optimising Market/Patient Access
With Prof. Dr Thomas Wilke
🎓 What you will learn:
- The expectations of external stakeholders regarding RWE throughout the product lifecycle.
- The fundamental concepts, methodologies, and research techniques of RWE in the context of optimising Market Access.
- Types of data and their strengths & weaknesses.
- Critical success factors of an RWE study.
- How to prepare for new developments in RWE generation.
HEALTH ECONOMICS:
2-day face-to-face course in Brussels:
Health Economics for Non-Health-Economists
With Prof. Dr Lieven Annemans
1-day live online course:
Basics of Health Economics
With Prof. Dr Lieven Annemans
🎓 What you will learn:
- The logic and mathematics behind QALYs, ICERs, decision trees and Markov models.
- How external stakeholders use and challenge health economic evidence.
- Key principles of cost-effectiveness analysis and Budget Impact Analysis.
- The role of health economic evaluations in clinical research, pricing & reimbursement decisions, and post-launch.
HEALTH TECHNOLOGY ASSESSMENT:
Critical New HTA Developments in Europe: Challenges & Solutions
With Prof. Dr Lieven Annemans
🎓 What you will learn:
- The different types of HTA processes in Europe and how they inform decision-making.
- How HTA bodies combine a variety of evaluation criteria, and what this means for value assessment.
- Key principles and common pitfalls in clinical evidence generation from an HTA perspective.
- The role of Real-World Data in HTA, including its strengths, limitations, and appropriate use across the lifecycle.
- What the Joint Clinical Assessment (JCA) will change, how to anticipate its implications, and how to prepare at a strategic level.
CROSS-FUNCTIONAL PHARMA LIFECYCLE :
Inside Pharma
With Chris Toller
🎓 What you will learn:
- How the pharma industry really works end to end, from early discovery through to patients.
- How companies choose where to invest, balancing science, unmet need, and commercial potential.
- How a medicine moves through development, clinical trials, and regulatory approval.
- How successful products are positioned, launched, and scaled across global and local markets.
- How Medical Affairs, market access, and pricing decisions drive real-world uptake and value.
- How to navigate cross-functional collaboration and understand where you fit in the bigger picture.
Are you ready to take your career in the pharmaceutical industry to the next level? 🚀
Discover CELforPharma's complete course portfolio, including topics you work on in cross-functional teams:
Our courses are also featured on Findcourses.co.uk
WANT TO ORGANISE AN IN-COMPANY COURSE?
